MedPath

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

Phase 3
Completed
Conditions
Malaria
Childhood ALL
Vector Borne Diseases
Registration Number
NCT06179732
Lead Sponsor
The Mentor Initiative
Brief Summary

The aim of this study is to determine the effectiveness of a new spatial repellent (called Mesh) at repelling multiple disease vectors and, reducing clinical malaria rates in temporary shelters and camp settings. The design of the study will be a two-armed cluster randomised trial.

By conducting the research in challenging camp settings in the north of Nigeria, the MENTOR Initiative aims to determine whether Mesh can be effective in harsh camp conditions where communities are living in conflict area temporary shelters.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2400
Inclusion Criteria
  • Shelters with 1 or more children from 6-10 years old
  • Shelters with an adult/head of the household
Exclusion Criteria
  • Shelters without children from 6-10 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
epidemiological outcome: malaria incidence7 months

Malaria incidence will be estimated as the total number of malaria episodes per person over the course of the trial.

entomological outcome: vector density7 months

the relative infestation rate of disease vectors (females of any of Anopheles malaria vectors, Aedes aegypti, or phlebotomine sand flies

Secondary Outcome Measures
NameTimeMethod
feasibility, acceptance and uptake of Mesh7 months

To measure community and household acceptance and uptake of Mesh, a questionnaire will be conducted with the Mesh-receiving households.

Trial Locations

Locations (1)

Sara Estecha Querol

🇬🇧

Haywards Heath, West Sussex, United Kingdom

Sara Estecha Querol
🇬🇧Haywards Heath, West Sussex, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.